Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3508240018 | Parecoxib sodium (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3508241019 | Parecoxib sodium | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
41031000188118 | parécoxib sodium | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
831231000172113 | parécoxib sodique | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Parecoxib sodium (substance) | Is a | Parecoxib (substance) | false | Inferred relationship | Some | ||
Parecoxib sodium (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Cyclooxygenase-2 inhibitor | true | Inferred relationship | Some | ||
Parecoxib sodium (substance) | This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. | Parecoxib (substance) | true | Inferred relationship | Some | ||
Parecoxib sodium (substance) | Is a | Isoxazole (substance) | true | Inferred relationship | Some | ||
Parecoxib sodium (substance) | Is a | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely parecoxib (as parecoxib sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | True | Parecoxib sodium (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets